December 2023

In a first, Centre spells out rules for ICU admissions – ET HealthWorld

In a first, Centre spells out rules for ICU admissions – ET HealthWorld

They list out the medical conditions under which a patient requires admission in ICU, like “an altered level of consciousness or if the patient needs respiratory support”. ICU care has also been recommended in cases of severe acute illness requiring intensive monitoring; medical condition which is likely to deteriorate in post-surgery cases; and for patients […]

In a first, Centre spells out rules for ICU admissions – ET HealthWorld Read More »

Do we need COVID vax, Maharashtra asks task force – ET HealthWorld

Do we need COVID vax, Maharashtra asks task force – ET HealthWorld

Mumbai: The state government has sought the opinion of the newly formed task force on whether to invest in COVID vaccine doses, considering the surge in coronavirus cases driven by the new variant JN.1. Currently, the state is sitting on an unused inventory of 16,000 doses of intranasal vaccine iNCOVACC that was procured in April

Do we need COVID vax, Maharashtra asks task force – ET HealthWorld Read More »

At 841, India’s daily Covid cases hit 7-month high; 3 more deaths reported – ET HealthWorld

At 841, India’s daily Covid cases hit 7-month high; 3 more deaths reported – ET HealthWorld

New Delhi: India has reported 841 new cases of COVID-19, the highest in 227 days, while the number of active cases of the infection was recorded at 4,309, a health ministry bulletin stated on Sunday. Three fresh deaths – one each from Kerala, Karnataka and Bihar – were also reported in 24 hours, data showed.

At 841, India’s daily Covid cases hit 7-month high; 3 more deaths reported – ET HealthWorld Read More »

‘Disappointed’ IQVIA hit by judge’s decision to uphold FTC’s block of its DeepIntent buyout

‘Disappointed’ IQVIA hit by judge’s decision to uphold FTC’s block of its DeepIntent buyout

A U.S. judge has upheld the Federal Trade Commission’s (FTC) decision to block IQVIA’s long-running attempt to buy the owner of pharma digital ad specialist DeepIntent. The long-running saga centers on IQVIA, the leading biopharma data provider, and its attempt to snap up Propel Media for its DeepIntent business. IQVIA tried to buy Propel back

‘Disappointed’ IQVIA hit by judge’s decision to uphold FTC’s block of its DeepIntent buyout Read More »

Tata Hospital with Bangalore lab develop India’s first oral suspension for leukemia – ET HealthWorld

Tata Hospital with Bangalore lab develop India’s first oral suspension for leukemia – ET HealthWorld

Mumbai: Doctors from Mumbai’s Tata Memorial Centre in collaboration with IDRS Labs in Bangalore have developed India’s first and only chemotherapy drug, 6-mercaptopurine (6-MP), to be available in a syrup form. This drug is crucial to combat Acute Lymphoblastic Leukemia (ALL), the commonest form of blood cancer affecting children. Approximately 10,000 children in the age

Tata Hospital with Bangalore lab develop India’s first oral suspension for leukemia – ET HealthWorld Read More »

McKinsey to pay $78 million in US opioid settlement with health plans – ET HealthWorld

McKinsey to pay $78 million in US opioid settlement with health plans – ET HealthWorld

Boston: Consulting firm McKinsey & Co has agreed to pay $78 million to resolve claims by U.S. health insurers and benefit plans that it fueled an epidemic of opioid addiction through its work for drug companies including OxyContin maker Purdue Pharma. The settlement was disclosed in papers filed on Friday in federal court in San

McKinsey to pay $78 million in US opioid settlement with health plans – ET HealthWorld Read More »

Scroll to Top